Anthony Pilorget, PhD, MBA, CA-AM
Director, Alliance Management and Strategy at NOVAVAX INC- Claim this Profile
Click to upgrade to our gold package
for the full feature experience.
-
French Native or bilingual proficiency
-
English Full professional proficiency
-
Spanish Elementary proficiency
-
Romanian Full professional proficiency
-
German Elementary proficiency
-
Italian Professional working proficiency
Topline Score
Bio
LinkedIn User
I have worked with Anthony for a number of years. Anthony has a rare skill set of combining both science, business and management leadership where he is able to capitalise on delivering scientific value and benefit to patients through innovative collaborative strategies. He has an attention to detail which is second to none, whilst being able to look at the big picture. He provides global inspirational leadership to his team with an entrepreneurial mindset to problem solve and create win- win solutions to accelerate vaccines development. Anthony is a team player, highly professional and with a strong work ethic is an asset to any organization. I highly recommend him.
Mathias Kroll Ph.D. M.B.A. (IMD) GAICD
Anthony is a very creative and enthusiastic scientific expert with responsibility for generating, evaluating, and executing new vaccine and immunotherapy opportunities. He is never shy of taking on extra responsibility, volunteering often and always contributing his own input for consideration by the team. He delivers by steering large cross-functional project teams with members based in different sites, on two or more continents, to produce the desired outcome. Anthony is also an eager learner in science, commercial, and business dealings and with his drive and humour, it is a pleasure working with him.
Pedro Alves
Although separated by the Atlantic, we have developed close collaboration in multiple aspects of our business roles. Anthony is a great partner, very responsive and pro-active in finding solutions for pertinent problems, facilitating project development.
LinkedIn User
I have worked with Anthony for a number of years. Anthony has a rare skill set of combining both science, business and management leadership where he is able to capitalise on delivering scientific value and benefit to patients through innovative collaborative strategies. He has an attention to detail which is second to none, whilst being able to look at the big picture. He provides global inspirational leadership to his team with an entrepreneurial mindset to problem solve and create win- win solutions to accelerate vaccines development. Anthony is a team player, highly professional and with a strong work ethic is an asset to any organization. I highly recommend him.
Mathias Kroll Ph.D. M.B.A. (IMD) GAICD
Anthony is a very creative and enthusiastic scientific expert with responsibility for generating, evaluating, and executing new vaccine and immunotherapy opportunities. He is never shy of taking on extra responsibility, volunteering often and always contributing his own input for consideration by the team. He delivers by steering large cross-functional project teams with members based in different sites, on two or more continents, to produce the desired outcome. Anthony is also an eager learner in science, commercial, and business dealings and with his drive and humour, it is a pleasure working with him.
Pedro Alves
Although separated by the Atlantic, we have developed close collaboration in multiple aspects of our business roles. Anthony is a great partner, very responsive and pro-active in finding solutions for pertinent problems, facilitating project development.
LinkedIn User
I have worked with Anthony for a number of years. Anthony has a rare skill set of combining both science, business and management leadership where he is able to capitalise on delivering scientific value and benefit to patients through innovative collaborative strategies. He has an attention to detail which is second to none, whilst being able to look at the big picture. He provides global inspirational leadership to his team with an entrepreneurial mindset to problem solve and create win- win solutions to accelerate vaccines development. Anthony is a team player, highly professional and with a strong work ethic is an asset to any organization. I highly recommend him.
Mathias Kroll Ph.D. M.B.A. (IMD) GAICD
Anthony is a very creative and enthusiastic scientific expert with responsibility for generating, evaluating, and executing new vaccine and immunotherapy opportunities. He is never shy of taking on extra responsibility, volunteering often and always contributing his own input for consideration by the team. He delivers by steering large cross-functional project teams with members based in different sites, on two or more continents, to produce the desired outcome. Anthony is also an eager learner in science, commercial, and business dealings and with his drive and humour, it is a pleasure working with him.
Pedro Alves
Although separated by the Atlantic, we have developed close collaboration in multiple aspects of our business roles. Anthony is a great partner, very responsive and pro-active in finding solutions for pertinent problems, facilitating project development.
LinkedIn User
I have worked with Anthony for a number of years. Anthony has a rare skill set of combining both science, business and management leadership where he is able to capitalise on delivering scientific value and benefit to patients through innovative collaborative strategies. He has an attention to detail which is second to none, whilst being able to look at the big picture. He provides global inspirational leadership to his team with an entrepreneurial mindset to problem solve and create win- win solutions to accelerate vaccines development. Anthony is a team player, highly professional and with a strong work ethic is an asset to any organization. I highly recommend him.
Mathias Kroll Ph.D. M.B.A. (IMD) GAICD
Anthony is a very creative and enthusiastic scientific expert with responsibility for generating, evaluating, and executing new vaccine and immunotherapy opportunities. He is never shy of taking on extra responsibility, volunteering often and always contributing his own input for consideration by the team. He delivers by steering large cross-functional project teams with members based in different sites, on two or more continents, to produce the desired outcome. Anthony is also an eager learner in science, commercial, and business dealings and with his drive and humour, it is a pleasure working with him.
Pedro Alves
Although separated by the Atlantic, we have developed close collaboration in multiple aspects of our business roles. Anthony is a great partner, very responsive and pro-active in finding solutions for pertinent problems, facilitating project development.
Credentials
-
Certificate of Achievement-Alliance Management (CA-AM)
Association of Strategic Alliance ProfessionalsJun, 2019- Nov, 2024
Experience
-
Novavax
-
United States
-
Pharmaceutical Manufacturing
-
700 & Above Employee
-
Director, Alliance Management and Strategy
-
Mar 2022 - Present
-
-
-
Eureka Network
-
Belgium
-
Research Services
-
1 - 100 Employee
-
Project Evaluation Expert
-
Jun 2019 - Present
-
-
-
Medicines Patent Pool
-
Switzerland
-
Non-profit Organizations
-
1 - 100 Employee
-
Head of Alliance Management
-
Mar 2021 - Dec 2021
-
-
-
GSK
-
United Kingdom
-
Pharmaceutical Manufacturing
-
700 & Above Employee
-
Director - Alliance Manager
-
Oct 2014 - Mar 2021
Following acquisition of Okairos AG by GSK, in charge of strategy and operations regarding:• Liaison between Okairos AG management team and GSK• Company Integration • New R&D operating model set-up and improvement• Platform technology management and value creation management• R&D program management
-
-
Director - Adenovirus Platform Technology Project Leader
-
Jan 2016 - Jan 2018
-
-
Manager Extramural and Preclinical R&D - Chronic Disorders Group
-
Jan 2010 - Oct 2014
In this position, I'm managing a preclinical research team responsible for the development of new immunotherapies to treat allergic and autoimmune diseases. In addition, I'm in charge of the evaluation of new business opportunities in the field of autoimmunity.
-
-
Scientist - Antigen-Specific Cancer Immunotherapy
-
Nov 2006 - Jan 2010
In this position, I was in charge of the preclinical validation of a new Antigen-Specific Cancer immunotherapy to treat colorectal cancer.
-
-
-
Université de Montréal
-
Higher Education
-
700 & Above Employee
-
Course Lecturer
-
Feb 2009 - Jan 2015
At the University of Montreal, I'm in charge of giving a lecture on brain tumors within a course focused on CNS diseases. At the University of Montreal, I'm in charge of giving a lecture on brain tumors within a course focused on CNS diseases.
-
-
-
UQAM | Université du Québec à Montréal
-
Canada
-
Higher Education
-
700 & Above Employee
-
Teaching assistant
-
Jul 2002 - Jul 2006
Laboratory practice training for undergraduate programs Laboratory practice training for undergraduate programs
-
-
-
UQAM | Université du Québec à Montréal
-
Canada
-
Higher Education
-
700 & Above Employee
-
Summer fellow
-
Apr 2000 - Sep 2000
Undergraduate internship Undergraduate internship
-
-
Education
-
HEC Montréal
MBA, International Management & Marketing -
Université du Québec à Montréal
Ph.D., Biochemistry -
Aix-Marseille University
Doctorate, Cancer Cell Biology -
Aix-Marseille University
Master of Science (M.Sc.), Genetics -
Université de Rennes I
Bachelor of Science (B.Sc.), Cell Biology and Physiology